Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
2.290
-0.020 (-0.87%)
Dec 30, 2024, 4:00 PM EST - Market closed
Minerva Neurosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | - | - | - | - | 41.18 | - | Upgrade
|
| Cost of Revenue | 12.4 | 12.71 | 14.65 | 16.84 | 22.04 | 39.12 | Upgrade
|
| Gross Profit | -12.4 | -12.71 | -14.65 | -16.84 | 19.14 | -39.12 | Upgrade
|
| Selling, General & Admin | 9.86 | 10.41 | 10.58 | 13.33 | 17.29 | 17.74 | Upgrade
|
| Research & Development | 2.24 | - | - | - | - | - | Upgrade
|
| Operating Expenses | 12.1 | 10.41 | 10.58 | 13.33 | 17.29 | 17.74 | Upgrade
|
| Operating Income | -24.5 | -23.12 | -25.23 | -30.17 | 1.85 | -56.87 | Upgrade
|
| Interest Expense | -6.75 | -8.28 | -7.41 | -6.33 | - | - | Upgrade
|
| Interest & Investment Income | 1.39 | 1.44 | 0.56 | 0.02 | 0.16 | 1.46 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.03 | -0.04 | -0.03 | -0.03 | -0.07 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | -3.31 | -30.01 | -32.11 | -36.51 | 1.94 | -55.44 | Upgrade
|
| Asset Writedown | - | - | - | -15.2 | - | -19 | Upgrade
|
| Pretax Income | -3.31 | -30.01 | -32.11 | -51.71 | 1.94 | -74.44 | Upgrade
|
| Income Tax Expense | - | - | - | -1.8 | - | -2.25 | Upgrade
|
| Net Income | -3.31 | -30.01 | -32.11 | -49.91 | 1.94 | -72.18 | Upgrade
|
| Net Income to Common | -3.31 | -30.01 | -32.11 | -49.91 | 1.94 | -72.18 | Upgrade
|
| Shares Outstanding (Basic) | 8 | 7 | 5 | 5 | 5 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 8 | 7 | 5 | 5 | 5 | 5 | Upgrade
|
| Shares Change (YoY) | 27.34% | 21.84% | -0.00% | 4.41% | 4.88% | 0.57% | Upgrade
|
| EPS (Basic) | -0.44 | -4.61 | -6.01 | -9.35 | 0.38 | -14.80 | Upgrade
|
| EPS (Diluted) | -0.44 | -4.61 | -6.01 | -9.35 | 0.38 | -14.80 | Upgrade
|
| Free Cash Flow | -20.38 | -14.78 | -24.66 | -24.6 | -33.82 | -43.43 | Upgrade
|
| Free Cash Flow Per Share | -2.69 | -2.27 | -4.62 | -4.61 | -6.61 | -8.91 | Upgrade
|
| Gross Margin | - | - | - | - | 46.47% | - | Upgrade
|
| Operating Margin | - | - | - | - | 4.49% | - | Upgrade
|
| Profit Margin | - | - | - | - | 4.71% | - | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | -82.14% | - | Upgrade
|
| EBITDA | -24.49 | -23.11 | - | -30.15 | 1.86 | -56.85 | Upgrade
|
| EBITDA Margin | - | - | - | - | 4.52% | - | Upgrade
|
| D&A For EBITDA | 0.01 | 0.01 | - | 0.02 | 0.02 | 0.02 | Upgrade
|
| EBIT | -24.5 | -23.12 | -25.23 | -30.17 | 1.85 | -56.87 | Upgrade
|
| EBIT Margin | - | - | - | - | 4.49% | - | Upgrade
|
| Revenue as Reported | - | - | - | - | 41.18 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.